Free Trial

JPMorgan Chase & Co. Issues Pessimistic Forecast for Rentokil Initial (LON:RTO) Stock Price

Rentokil Initial logo with Industrials background

Rentokil Initial (LON:RTO - Free Report) had its price target decreased by JPMorgan Chase & Co. from GBX 440 ($5.37) to GBX 430 ($5.25) in a report issued on Tuesday, MarketBeat reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Rentokil Initial Stock Performance

Shares of Rentokil Initial stock traded down GBX 5.10 ($0.06) during trading on Tuesday, hitting GBX 377.50 ($4.61). 3,039,990 shares of the company's stock were exchanged, compared to its average volume of 75,605,219. The stock has a market capitalization of £9.48 billion, a price-to-earnings ratio of 2,359.38, a PEG ratio of 0.56 and a beta of 0.55. The business has a 50-day simple moving average of GBX 398.53 and a 200-day simple moving average of GBX 422.58. Rentokil Initial has a 52-week low of GBX 336.30 ($4.11) and a 52-week high of GBX 517.60 ($6.32). The company has a debt-to-equity ratio of 116.58, a quick ratio of 1.76 and a current ratio of 1.04.

Insider Activity

In other news, insider Brian Baldwin bought 7,500,000 shares of the business's stock in a transaction dated Wednesday, December 11th. The stock was purchased at an average cost of GBX 413 ($5.04) per share, with a total value of £30,975,000 ($37,815,895.50). Insiders own 0.32% of the company's stock.

Rentokil Initial Company Profile

(Get Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

Featured Articles

Should You Invest $1,000 in Rentokil Initial Right Now?

Before you consider Rentokil Initial, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.

While Rentokil Initial currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines